Peptide reference standards: read the certificate
Check which property a peptide reference standard supports. Use a fictional certificate example to separate identity, concentration, uncertainty and sample traceability.
The research blog
Read the evidence. Ask better questions.
Practical peptide research guides, with original sources and useful checks for your next study, comparison or lab report.
A clearer starting point
Find the guide for your question.
10 guides to explore
Peptide retention time: read the chromatogram
Read retention time with its method and reference. A fictional chromatogram comparison shows which details to request before treating two peaks as a match.
CJC-1295 with DAC versus no DAC: match the exact form
Resolve CJC-1295 naming before comparing sources. Check the DAC modification, full structure and study material instead of transferring evidence between names.
How to compare peptide studies without losing context
Build a source-linked comparison of peptide studies. Align exact compounds, models, outcomes and time points while keeping unmatched evidence visible.
How to read a peptide COA
Read a peptide certificate of analysis step by step. Separate batch identity, purity, quantity and missing tests, then prepare useful supplier questions.
HPLC vs LC-MS: how to read a peptide report
Compare HPLC and LC-MS results on a peptide COA. Work through a fictional report, separate identity from quantity, and use a checklist of questions for the lab.
Peptide COA red flags: questions before conclusions
Review COA inconsistencies without guessing at fraud. Check batch links, missing methods, edited reports and unsupported claims with a practical exception log.
Peptide purity versus content: what the numbers mean
Understand the difference between chromatographic purity and peptide amount, including why a percentage cannot be converted directly into milligrams per vial.
Preclinical versus clinical peptide research
Read peptide evidence in context. Distinguish laboratory, animal and human studies, then check the design, measured outcome and limits of each claim.
TB-500 versus thymosin beta-4: fragment and parent
Understand why TB-500 and full-length thymosin beta-4 need separate evidence records, including the limits of transferring an ophthalmic trial to a fragment.
Looking for a quick definition? Read the short research notes. For the original studies behind the Atlas, open the source register.
Keep the guide with your research.
Build a free pack with your selected compounds, source links and a checklist for the question you are working on.
Build a research pack